Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas are both associated with inferior outcomes after autologous stem cell transplant in patients with rel/ref DLBCL. Although ASCT remains a potentially curative approach, these patients, particularly those with DHL, are a high-risk subset who should be targeted for investigational strategies other than standard ASCT.
Home / Resource Library / Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation